NASDAQ: IOVA - Iovance Biotherapeutics, Inc.

Yield per half year: -53.77%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Iovance Biotherapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc., биотехнологическая компания, работающая на клинической стадии, специализируется на разработке и коммерциализации продуктов иммунотерапии рака, чтобы использовать силу иммунной системы пациента для уничтожения раковых клеток. К основным кандидатам в продуктах компании относятся lifileucel, которая проходит II фазу клинических испытаний для лечения метастатической меланомы; и LN-145 для лечения метастатического рака шейки матки.

more details
Он также разрабатывает методы лечения инфильтрирующих опухоль лимфоцитов (TIL) и лимфоцитов периферической крови для лечения плоскоклеточного рака головы и шеи, немелкоклеточного рака легкого и хронического лимфолейкоза в рамках спонсируемых им исследований, а также в других онкологиях. указания через сотрудничество. Iovance Biotherapeutics, Inc. имеет соглашения о сотрудничестве с Моффиттом, онкологическим центром доктора медицины Андерсона, Университетом штата Огайо и MedImmune; и исследовательское сотрудничество с Cellectis S.A. Компания ранее была известна как Lion Biotechnologies, Inc. и сменила название на Iovance Biotherapeutics, Inc. в июне 2017 года. Iovance Biotherapeutics, Inc. была основана в 2007 году, ее штаб-квартира находится в Сан-Карлосе, Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2010-10-15
ISIN US4622601007
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.iovance.com
Цена ао 5.39
Change price per day: +0.9363% (5.34)
Change price per week: -4.6% (5.65)
Change price per month: -13.76% (6.25)
Change price per 3 month: -42.66% (9.4)
Change price per half year: -53.77% (11.66)
Change price per year: -69.08% (17.43)
Change price per 3 year: -68.7% (17.22)
Change price per 5 year: -80.19% (27.21)
Change price per 10 year: -54.82% (11.93)
Change price per year to date: -24.83% (7.17)
All parameters

Underestimation

Title Value Grade
P/S 1649.28 1
P/BV 3.35 5
P/E 0 0
EV/EBITDA -4.5 0
Total: 3.25

Efficiency

Title Value Grade
ROA, % -56.9 0
ROE, % -75.95 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0205 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 399.58 10
Yield Ebitda, % 106.59 10
Yield EPS, % 25.9 4
Total: 8.8
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
15.04.2024 17.04.2024 BILINSKY IGOR
Chief Operating Officer		 Purchase 11.8 33 182 2812 0 0 link
15.04.2024 17.04.2024 GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer		 Purchase 11.8 33 182 2812 0 0 link
15.04.2024 17.04.2024 Vogt Frederick G
Interim CEO & General Counsel		 Purchase 11.8 245 841 20834 0 0.01 link
04.03.2024 06.03.2024 Vogt Frederick G
Interim CEO & General Counsel		 Purchase 17.15 714 503 41662 0 0.03 link
04.03.2024 06.03.2024 GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer		 Purchase 17.15 267 934 15623 0 0.01 link
16.01.2024 18.01.2024 BILINSKY IGOR
Chief Operating Officer		 Purchase 7.94 22 335 2813 0 0 link
16.01.2024 18.01.2024 GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer		 Purchase 7.94 22 335 2813 0 0 link
16.01.2024 18.01.2024 Vogt Frederick G
Interim CEO & General Counsel		 Purchase 7.94 165 422 20834 0 0.01 link

Institutions Volume Share, %
Vanguard Group Inc 22812820 8.17
MHR Fund Management, LLC 19997103 7.16
Blackrock Inc. 19071756 6.83
State Street Corporation 16424388 5.88
Perceptive Advisors LLC 11979415 4.29
Avoro Capital Advisors LLC 6700000 2.4
Pictet Asset Management Holding SA 5263309 1.88
Geode Capital Management, LLC 5037098 1.8
Artisan Partners Limited Partnership 4827670 1.73
Orbimed Advisors LLC. 4707458 1.69

ETF Share, % Profitability for 1 year, % Dividends, %
WisdomTree BioRevolution Fund 1.89129 -4.69 0.78691
Virtus LifeSci Biotech Products ETF 1.77889 36.79 0.13953
Range Cancer Therapeutics ETF 0.97828 47.24 0.11955
Direxion Daily S&P Biotech Bull 3x Shares 0.57729 4067.92 0.25924
ProShares UltraShort Nasdaq Biotechnology 0.36 -40.36 1.76
Future Tech ETF 0.29888 426.34 0.8416
Principal Healthcare Innovators ETF 0.29888 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.27891 28.58 0.8565
Vanguard Russell 2000 Growth ETF 0.22 23.05 0.60264
iShares Russell 2000 Growth ETF 0.1899 38.04 0.6026
ProShares Ultra Nasdaq Biotechnology 0.18913 51.7 0.85651
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.14791 24.75 1.59225
BNY Mellon US Small Cap Core Equity ETF 0.14079 30.07 1.75333
SPDR S&P Kensho New Economies Composite ETF 0.11099 21.57 0.88486
Vanguard Russell 2000 ETF 0.11 17.16 1.48801
iShares Morningstar Small-Cap Growth ETF 0.09458 587.89 0.72598
iShares Morningstar Small-Cap Growth ETF 0.09458 33.63 0.72598
Vanguard Small Cap Value ETF 0.09 17.27 2.19419
Vanguard U.S. Momentum Factor ETF 0.08 30.05 1.05834
Schwab U.S. Small-Cap ETF 0.06379 17.47 1.51433
ProShares UltraPro Russell2000 0.05552 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.04826 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.04826 391.25 1.60498
iShares U.S. Tech Breakthrough Multisector ETF 0.04211 21.8 0.73986
Fidelity MSCI Health Care Index ETF 0.02943 3 1.46057
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.02795 31.36 1.41955
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02105 17.58 1.75869
Dimensional U.S. Core Equity 2 ETF 0.01663 30.76 1.47098
Humankind US Stock ETF 0.01581 18.81 1.99919
ProShares Hedge Replication ETF 0.01571 5.92 1.47892
Vanguard Russell 3000 ETF 0.01 31.87 1.43817
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00799 21.94 1.69572
Dimensional US Core Equity Market ETF 0.00455 30.98 1.40618
Schwab U.S. Broad Market ETF 0.00437 24.86 1.43354
iShares Russell 3000 ETF 0.00436 24.83 1.43482
Dimensional U.S. Equity ETF 0.00372 31.53 1.3557
Avantis U.S. Equity ETF 0.00365 23.04 1.59151
SPDR Portfolio MSCI Global Stock Market ETF 0.00198 17.99 2.19607
Vanguard ESG U.S. Stock ETF 0 23.54 1.26927



Head Job title Payment Year of birth
Mr. Jean-Marc Bellemin M.B.A. CFO, Principal Accounting Officer & Treasurer 932.2k 1972 (53 years)
Dr. Friedrich Graf Finckenstein M.D. Chief Medical Officer 1.06M 1967 (58 years)
Ms. Sara Pellegrino Vice President of Investor Relations & Public Relations N/A
Dr. Frederick G. Vogt Esq., J.D., Ph.D. Interim CEO, President, General Counsel, Corporate Secretary & Director 1.39M 1974 (51 year)
Mr. Howard B. Johnson M.B.A. Chief Business Officer N/A 1960 (65 years)
Dr. Igor P. Bilinsky Ph.D. Chief Operating Officer 1973 (52 years)
Ms. Tracy Winton Executive Vice President of Human Resources
Dr. Raj K. Puri M.D., Ph.D. Executive VP of Regulatory Strategy & Translational Medicine
Mr. Brian Shew M.B.A. Senior VP & Head of Digital and Information Technology
Mr. Kevin Smyth Executive Vice President of Quality

Address: United States, San Carlos, CA , 999 Skyway Road - open in Google maps, open in Yandex maps
Website: https://www.iovance.com